SCHEMBL651697

SCHEMBL651697

CCCCn1c(-c2ccncc2)nc(-c2ccc(OC)cc2)c1CN(Cc1ccc(N)c(O)c1)CC1CCCCC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 1/20 0.37
TEK Q02763 3/20 0.35
SLC2A1 P11166 1/20 0.33
BCHE P06276 2/20 0.33
C5AR1 P21730 1/20 0.33
CNR2 P34972 1/20 0.32
ITK Q08881 1/20 0.32
HTR6 P50406 1/20 0.32
PDE5A O76074 1/20 0.31
OXTR P30559 3/20 0.31
AVPR1A P37288 3/20 0.31
AVPR1B P47901 3/20 0.31
MEN1 O00255 1/20 0.31
ALDH1A1 P00352 1/20 0.31
LMNA P02545 1/20 0.31
MAPT P10636 1/20 0.31
CRHBP P24387 1/20 0.31
HTT P42858 1/20 0.31
KMT2A Q03164 1/20 0.31
CRHR2 Q13324 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL651698 0.91 NPC1 (0.36) PDE4BTEKSLC2A1BCHECNR2
SCHEMBL648105 0.85 C5AR1 (0.38) BCHEC5AR1CNR2AVPR1BMEN1
SCHEMBL650630 0.83 MKNK1 (0.36) ITKMEN1ALDH1A1LMNAMAPT
SCHEMBL5137557 0.83 C5AR1 (0.42) BCHEC5AR1MEN1ALDH1A1LMNA
SCHEMBL14099616 0.82 ALOX5 (0.34) PDE4BBCHEC5AR1CNR2HTR6
SCHEMBL4766337 0.82 C5AR1 (0.38) BCHEC5AR1CNR2MEN1ALDH1A1
SCHEMBL651696 0.81 PDE4B (0.36) PDE4BTEKPDE5AOXTRAVPR1A
SCHEMBL5137356 0.79 MEN1 (0.45) PDE4BC5AR1CNR2MEN1ALDH1A1
SCHEMBL648304 0.79 C5AR1 (0.41) BCHEC5AR1MEN1ALDH1A1KMT2A
SCHEMBL5225249 0.78 C5AR1 (0.38) BCHEC5AR1CNR2AVPR1BMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8119665-B2 Aryl imidazoles and related compounds as C5a receptor modulators NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. (BM) 2012-02-21 US disclosed